This delivery system may offer significant advantages for the use of platinum medicines in the management of locally advanced cancers, treating microscopic lymph node disease with better efficacy than current high-dose systemic chemotherapy. Currently, we have generated a drug candidate (CPHC008) and processed the pilot scale up.
-Patentable HA polymer modification
-Organic solvent-free nanocarriersprocess
-Active targeting to lymph node and tumor
Booth No. L1010